Minireviews Open Access
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jul 7, 2013; 19(25): 3951-3956
Published online Jul 7, 2013. doi: 10.3748/wjg.v19.i25.3951
Exposure to ambient air particulate matter and non-alcoholic fatty liver disease
Giovanni Tarantino, Department of Clinical Medicine and Surgery, Federico II University Medical School of Naples, 80131 Naples, Italy
Giovanni Tarantino, INT “Fondazione Pascale” - Cancer Research Center of Mercogliano, 83013 Mercogliano, Italy
Domenico Capone, Unit of Clinical Pharmacology, Department of Neuroscience, Federico II University Medical School of Naples, 80131 Naples, Italy
Carmine Finelli, Center of Obesity and Eating Disorders, Stella Maris Mediterraneum Foundation, C/da S. Lucia, Chiaromonte, 80035 Potenza, Italy
Author contributions: Tarantino G designed research and analyzed data; Finelli C performed research of literature data and wrote the paper; Capone D critically revised the paper.
Correspondence to: Giovanni Tarantino, MD, Professor, Department of Clinical Medicine and Surgery, Federico II University Medical School of Naples, Via Sergio Pansini 5, 80131 Naples, Italy. tarantin@unina.it
Telephone: +39-81-7462024 Fax: +39-81-5466154
Received: February 25, 2013
Revised: April 7, 2013
Accepted: June 1, 2013
Published online: July 7, 2013

Abstract

The present study was designed to alert the public opinion and policy makers on the supposed enhancing effects of exposure to ambient air particulate matter with aerodynamic diameters < 2.5 mm (PM2.5) on non-alcoholic fatty liver disease (NAFLD), the most common chronic liver disease in Western countries. For far too long literature data have been fixated on pulmonary diseases and/or cardiovascular disease, as consequence of particulate exposure, ignoring the link between the explosion of obesity with related syndromes such as NAFLD and air pollution, the worst characteristics of nowadays civilization. In order to delineate a clear picture of this major health problem, further studies should investigate whether and at what extent cigarette smoking and exposure to ambient air PM2.5 impact the natural history of patients with obesity-related NAFLD, i.e., development of non alcoholic steatohepatitis, disease characterized by a worse prognosis due its progression towards fibrosis and hepatocarcinoma.

Key Words: Non-alcoholic fatty liver disease, Particulate matter with aerodynamic diameters < 2.5 μm, Cytochrome P-450, Reactive oxygen species

Core tip: Important arguments Diesel exhaust particles are known to be major constituents of atmospheric particulate matter (PM) in metropolitan areas. Exposure to PM is positively associated with increases in the morbidity and daily mortality. Obesity-related health complications include cardiovascular disease, type 2 diabetes, hyperlipidemia, hypertension and non-alcoholic fatty liver disease (NAFLD). Exposure to ambient air PM may induce/worsen NAFLD.



INTRODUCTION

The rising incidence of obesity in today’s environment is associated with many obesity-related health complications, including cardiovascular disease, type 2 diabetes, hyperlipidemia, hypertension, and non-alcoholic fatty liver disease (NAFLD)[1-4]. This constellation is also recognized as the metabolic syndrome and is characterized by underlying insulin resistance. NAFLD or generally speaking hepatic steatosis is defined as the accumulation of lipid, primarily in the form of triacylglycerols in individuals who do not consume significant amounts of alcohol (< 20 g ethanol/d) and in whom other known causes of steatosis, such as certain drugs and toxins, have been excluded[5]. The spectrum of NAFLD includes simple fatty liver, non alcoholic steatohepatitis (NASH) characterized by inflammation, apoptosis, ballooning degeneration, Mallory hyaline, fibrosis, cirrhosis post NASH, hepatocellular carcinoma and advanced liver disease, which leads to liver-related death[5-10].

Some epidemiological studies, deeply informed and full of insights, have demonstrated that exposure to ambient particulate matter (PM) is positively associated with increases in the morbidity and daily mortality caused by diseases, including ischemic heart disease[11,12] and chronic obstructive pulmonary disease[13,14], which are closely related to life habits. Diabetes mellitus and its complications are the other typical diseases related to life habits. Over the past several decades, prevalence of type 2 diabetes mellitus has reached epidemic levels in Western countries[15], which is a significant public health interest. The prognosis of patients with diabetes mellitus is worsened generally by a variety of complications including macro- or micro-angiopathy[16], fatty liver[17-20], nephropathy and infection in the presence or absence of overweight/obesity. Some epidemiological studies have reported a positive association between mortality in patients with diabetes mellitus and ambient levels of PM[21,22].

Air pollutants expelled from diesel engine-powered automobiles include diesel exhaust particles (DEP), which are known to be major constituents of atmospheric PM in metropolitan areas. DEP generate reactive oxygen species (ROS)[23], through a non enzymatic process[24], or enzymatic reactions catalyzed by cytochrome P-450 (Cyp)[25]. Furthermore, DEP enhance the gene expression for Cyp enzymes[25]. DEP induce a variety of biological damage at least partly through oxidative stress[25].

The present study was designed to alert the public opinion, international media and policy makers on the negative effects of exposure to ambient air particulate matter with aerodynamic diameters < 2.5 mm on NAFLD, a most common chronic liver disease in Western countries, which represents the first indication of liver transplantation.

SMOKING AND NAFLD

A growing body of evidence supports the potential effects of exposure to some environmental factors on liver diseases. Environmental exposure related to toxic waste sites was associated with an increased prevalence of autoimmune liver disease[26,27]. Therefore, increasing attention is being given to the effects of environmental factors on liver diseases, including NAFLD. Several recent studies have too reported the association of smoking with the incidence of and acceleration of disease progression in NAFLD, as well as with advanced fibrosis in this process[28-32].

Cigarette smoke exposure, whether passive or active, carries a high disease burden worldwide[33] and is considered a worldwide major cause of preventable morbidity and mortality[34].

Yuan et al[35] provide novel evidence demonstrating that tobacco smoke exposure may accelerate the development of experimental NAFLD. The study extends an earlier report from the group showing that in apo B transgenic mice, chronic environmental (second-hand) smoke exposure is associated to features of atherosclerotic plaque initiation[36]. Using the same model, the former authors now show that exposure to second-hand smoke potentiates steatogenesis elicited by a high-fat diet, as assessed by red oil staining and hepatic triglyceride quantification[35]. Since increased hepatic lipogenesis has been shown to account for about 30% of triglyceride accumulation in steatotic livers[37], the investigators subsequently review the impact of second-hand smoke on liver lipogenic pathways. Interestingly, cultured hepatocyte cell lines exposed to second-hand smoke display enhanced accumulation of triglycerides and increased expression of acetyl CoA carboxylase (ACC) and fatty acid synthase (FAS), two key enzymes governing hepatic synthesis of fatty acids. These data therefore indicate that the steatogenic properties of tobacco smoke are at least partly explained by a direct effect on hepatocytes.

In deciphering molecular determinants underlying tobacco-dependent activation of lipogenesis, the research focus on two key regulators of lipid metabolism, Sterol regulatory element binding protein-1c (SREBP-1c) and AMP-activated protein kinase (AMP kinase). SREBPs are a family of basic-helix-loop-helix-leucine zipper transcription factors synthesized as inactive precursors embedded in the endoplasmic reticulum[38]. Activation of SREBPs requires proteolytic cleavage, thereby allowing nuclear translocation and transcriptional activation of target lipogenic genes[39]. Whereas SREBP-2 governs synthesis of cholesterol, SREBP-1c promotes biosynthesis of fatty acids by upregulating enzymes such as ACC and FAS. The serine/threonine protein kinase AMP kinase is an energy sensor that acts as a metabolic master switch[40]. The phosphorylated active form of the enzyme simultaneously inhibits energy-consuming biosynthetic pathways such as lipogenesis and activates ATP-producing catabolic pathways such as fatty acid oxidation[40]. It has been shown that AMP kinase inhibits fatty acid synthesis both by phosphorylating target lipogenic enzymes and downregulating expression of transcription factors such as SREBP-1c[41-43]. In accordance with these data, Yuan et al[35] demonstrated that second-hand smoke exposure inhibits phosphorylation and activation of AMP kinase, thereby resulting in increased SREBP-1 activity and enhancement of fatty acid synthesis. Zein et al[44] showed that cigarette smoking were associated with increased fibrosis severity in human NALFD, suggesting it may accelerate disease progression.

Moreover, Yuan et al[35] extends this assumption to NAFLD and provides compelling evidence indicating that tobacco smoke might alter the regulatory effect of AMP kinase on lipid metabolism. Future studies should closely investigate the clinical relevance of these findings. Nevertheless, in the meantime, tobacco cessation might be considered in the management of patients with NAFLD.

NAFLD AND AIR POLLUTION

The harmful effects of air pollutants on atherosclerotic cardiovascular diseases are well-documented[31]. These effects might be mediated through oxidative stress and insulin resistance[45], which are also known to have pivotal roles in the pathogenesis of fatty liver[46]. Therefore, it can be assumed that such environmental factors might be too associated with NAFLD. It is well-documented that DEP, which are major constituents of atmospheric PM in urban areas, generate ROS[47]. The ROS are generated via enzymatic reactions catalyzed by Cyp[48], or by a non-enzymatic route[49].

Folkmann et al[50] assessed the effects of oxidative stress elicited by DEP in the aorta, liver, and lungs of dyslipidemic ApoE(-/-) mice, at the age when visual plaques appeared in the aorta. Vascular effects secondary to pulmonary inflammation were omitted by injecting DEP into the peritoneum. Six hours later, the expression of inducible nitric oxide synthase mRNA increased in the liver. Injection of DEP did not induce inflammation or oxidative damage to DNA in the lungs and aorta. Therefore, the study proposed a direct effect of DEP on inflammation and oxidative damage to DNA in the liver of dyslipidemic mice[50].

Another study[51] evaluated the effects of following exposure of male C57BL/6 mice fed high fat chow to concentrated air particulate matter or filtered air for 6 wk, progression of NAFLD was evaluated by standardized histological assessment of hepatic inflammation and fibrosis. Progression of NAFLD was evaluated by histology cal examination of hepatic inflammation and fibrosis. Tan et al[51] indicated that ambient PM that reaches the liver has the potential to induce Kupffer cell cytokine secretion. Circulating fine PM may then accumulate in both atherosclerotic plaques and hepatic Kupffer cells[51]. The activation of cytokine release by Kupffer cells may then trigger inflammation and hepatic stellate cell collagen synthesis[51]. It is extraordinary that interleukin-6, the concentration of which increased up to 7-fold in the abovementioned study, is too significantly abundant in cases of human NAFLD[52]. Some human studies confirmed the harmful effects of environmental toxins on liver diseases.

Cave et al[53] has showed that non-obese chemical workers highly exposed to vinyl chloride may develop insulin resistance and toxicant-associated steatohepatitis. Limited data exists on the potential role of environmental pollution on liver disease in the general population. Another study was conducted, by Cave et al[54] always, on 4582 adult participants without viral hepatitis, hemochromatosis, or alcoholic liver disease, from the National Health and Nutrition Examination Survey in 2003-2004, to investigate whether environmental pollutants are associated with an elevation in serum alanine aminotransferase (ALT) and suspected NAFLD. The ORs for ALT elevation were estabilished across exposure quartiles for 17 pollutants, after adjustments for age, race/ethnicity, sex, body mass index, poverty income ratio, and insulin resistance[54]. It showed that exposure to polychlorinated biphenyls in addition heavy metals, evident lead and mercury, was correlated with unexplained ALT elevation, and increased adjusted ORs for ALT elevation in a dose-dependent form[54].

Therefore, a growing number of studies suggest that air pollution can aggravate the adverse effects of obesity and insulin resistance[29,55,56]. Similarly, some other studies have documented the association of exposure to air pollutants with metabolic syndrome, as well as predisposition to diabetes mellitus and aggravation of its complications[57-59]. Given the inflammatory and oxidative properties of air pollutants, in addition their association with insulin resistance and metabolic syndrome, and considering the interaction of the latter conditions with fatty changes in liver, more studies about the effects of environmental factors, notably air pollution, on NAFLD are warranted. The high susceptibility of the young age group to the harmful effects of air pollutants, especially pertaining to early stages of chronic diseases[13,60-64], further stresses that more attention should be given to preventing late-onset effects of air pollutants.

FUTURE DIRECTIONS

It has been reported that ambient PM containing elementary carbon, sulfate, heavy metals, and organic compounds can cause and enhance cardiopulmonary diseases[65,66]. DEP form a large constituent of ambient urban PM. Inhalation or intratracheal instillation of DEP or the components of DEP has been shown to enhance lung inflammation and asthma[67,68], and to deteriorate biological cardiovascular functions[69]. On the other hand, cardiovascular disorders are critical participants in life habit diseases. Diabetes mellitus is another typical life habit disease and is characterized by complicated cardiovascular risk factors[70-72]. In epidemiological studies, individuals with diabetes mellitus have higher risk for death from exposure to polluted ambient air[73,74]. However, few experimental studies have elucidated the association between ambient air pollution and NAFLD.

In fact, Zein et al[44] showed that smoking may accelerate the progression of human NALFD and these observations may support a recommendation of smoking cessation in patients with NAFLD. This recommendation is added to the general recommendations of dietetic or lifestyle approach right for NAFLD patients[75].

As reported by Tan et al[51], exposure to ambient air particulate matter with aerodynamic diameters < 2.5 μm (PM2.5) may be a significant risk factor for NAFLD progression. In other words, could air pollution be the so-called “second hit”, according to the well-known theory?

A better understanding of the impact of ambient PM exposure on NAFLD progression may require studies utilizing a variety of ambient PM sources[51].

CONCLUSION

So far it has been known that PM2.5 result from fuel combustion (motor vehicles, power generation, industrial facilities), residential fireplaces and wood stoves. PM2.5 are usually selected as indicators of air pollution since those particles cause morbidity[76]. In fact, PM2.5 alone exposure could cause inflammation via tumor necrosis factor alpha[77], endothelial function and autonomic nervous system injuries, ozone potentiating these effects[78].

Further studies should investigate the effects of long-lasting exposures to cigarette smoking and to ambient air PM2.5 on specific pathways of the hepatic metabolism, better delineating the cellular and molecular mechanisms involved. Importantly, very informative reports should clarify whether cigarette smoking, habit started at very young age, and early exposure to ambient air PM2.5 impact the obesity, also the adolescents’ one, and the obesity-related NAFLD, favouring development of NASH, disease characterized by a worse prognosis due its progression towards fibrosis, liver cirrhosis and hepatocarcinoma.

By modifying the natural history of patients with NAFLD, air pollution adds a new argument in the debate of regulating the toxic emissions.

Footnotes

P- Reviewer Koch TR S- Editor Gou SX L- Editor A E- Editor Li JY

References
1.  Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol. 2007;22:293-303.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 112]  [Cited by in F6Publishing: 130]  [Article Influence: 7.6]  [Reference Citation Analysis (0)]
2.  Tarantino G, Colao A, Capone D, Conca P, Tarantino M, Grimaldi E, Chianese D, Finelli C, Contaldo F, Scopacasa F. Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. J Biol Regul Homeost Agents. 2011;25:47-56.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Tarantino G, Finelli C, Colao A, Capone D, Tarantino M, Grimaldi E, Chianese D, Gioia S, Pasanisi F, Contaldo F. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase? J Transl Med. 2012;10:50.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 39]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
4.  Finelli C, Tarantino G. Is visceral fat reduction necessary to favour metabolic changes in the liver? J Gastrointestin Liver Dis. 2012;21:205-208.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology. 2009;49:306-317.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 416]  [Cited by in F6Publishing: 406]  [Article Influence: 27.1]  [Reference Citation Analysis (0)]
6.  Adams LA, Talwalkar JA. Diagnostic evaluation of nonalcoholic fatty liver disease. J Clin Gastroenterol. 2006;40 Suppl 1:S34-S38.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6807]  [Cited by in F6Publishing: 7400]  [Article Influence: 389.5]  [Reference Citation Analysis (5)]
8.  Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51:1820-1832.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 968]  [Cited by in F6Publishing: 964]  [Article Influence: 68.9]  [Reference Citation Analysis (0)]
9.  Kawai H, Nomoto M, Suda T, Kamimura K, Tsuchiya A, Tamura Y, Yano M, Takamura M, Igarashi M, Wakai T. Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis. World J Hepatol. 2011;3:15-23.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Finelli C, Tarantino G. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival? Hepatol Int. 2012;Oct; Epub ahead of print.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 9]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
11.  Son JY, Lee JT, Kim KH, Jung K, Bell ML. Characterization of fine particulate matter and associations between particulate chemical constituents and mortality in Seoul, Korea. Environ Health Perspect. 2012;120:872-878.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 114]  [Cited by in F6Publishing: 58]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
12.  Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study. Res Rep Health Eff Inst. 2009;5-71; discussion 73-89.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Nachman KE, Parker JD. Exposures to fine particulate air pollution and respiratory outcomes in adults using two national datasets: a cross-sectional study. Environ Health. 2012;11:25.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 46]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
14.  Ko FW, Hui DS. Air pollution and chronic obstructive pulmonary disease. Respirology. 2012;17:395-401.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 119]  [Cited by in F6Publishing: 130]  [Article Influence: 10.8]  [Reference Citation Analysis (0)]
15.  Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4438]  [Cited by in F6Publishing: 4217]  [Article Influence: 301.2]  [Reference Citation Analysis (3)]
16.  Shomali M. Diabetes treatment in 2025: can scientific advances keep pace with prevalence? Ther Adv Endocrinol Metab. 2012;3:163-173.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 20]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
17.  Shimizu Y. Liver in systemic disease. World J Gastroenterol. 2008;14:4111-4119.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  McNear S, Harrison SA. Current status of therapy in nonalcoholic Fatty liver disease. Therap Adv Gastroenterol. 2009;2:29-43.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
19.  Ismail MH. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic. Am J Med Sci. 2011;341:485-492.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 20]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
20.  Tziomalos K, Athyros VG, Karagiannis A. Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options. Curr Vasc Pharmacol. 2012;10:162-172.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 38]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
21.  Puett RC, Hart JE, Schwartz J, Hu FB, Liese AD, Laden F. Are particulate matter exposures associated with risk of type 2 diabetes? Environ Health Perspect. 2011;119:384-389.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 142]  [Cited by in F6Publishing: 78]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
22.  Schneider A, Alexis NE, Diaz-Sanchez D, Neas LM, Harder S, Herbst MC, Cascio WE, Buse JB, Peters A, Devlin RB. Ambient PM2.5 exposure up-regulates the expression of costimulatory receptors on circulating monocytes in diabetic individuals. Environ Health Perspect. 2011;119:778-783.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 20]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
23.  Siegel PD, Saxena RK, Saxena QB, Ma JK, Ma JY, Yin XJ, Castranova V, Al-Humadi N, Lewis DM. Effect of diesel exhaust particulate (DEP) on immune responses: contributions of particulate versus organic soluble components. J Toxicol Environ Health A. 2004;67:221-231.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 39]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
24.  Bai Y, Suzuki AK, Sagai M. The cytotoxic effects of diesel exhaust particles on human pulmonary artery endothelial cells in vitro: role of active oxygen species. Free Radic Biol Med. 2001;30:555-562.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 133]  [Cited by in F6Publishing: 132]  [Article Influence: 5.7]  [Reference Citation Analysis (0)]
25.  Ma JY, Ma JK. The dual effect of the particulate and organic components of diesel exhaust particles on the alteration of pulmonary immune/inflammatory responses and metabolic enzymes. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2002;20:117-147.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 114]  [Cited by in F6Publishing: 91]  [Article Influence: 4.1]  [Reference Citation Analysis (0)]
26.  Gilbert KM. Xenobiotic exposure and autoimmune hepatitis. Hepat Res Treat. 2010;2010:248157.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 8]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
27.  Mantaka A, Koulentaki M, Chlouverakis G, Enele-Melono JM, Darivianaki A, Tzardi M, Kouroumalis EA. Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence rates. BMC Gastroenterol. 2012;12:110.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 33]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
28.  Grønbaek H, Thomsen KL, Rungby J, Schmitz O, Vilstrup H. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. Expert Rev Gastroenterol Hepatol. 2008;2:705-711.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 32]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
29.  Azzalini L, Ferrer E, Ramalho LN, Moreno M, Domínguez M, Colmenero J, Peinado VI, Barberà JA, Arroyo V, Ginès P. Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology. 2010;51:1567-1576.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 95]  [Cited by in F6Publishing: 100]  [Article Influence: 7.1]  [Reference Citation Analysis (0)]
30.  Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4097]  [Cited by in F6Publishing: 3737]  [Article Influence: 266.9]  [Reference Citation Analysis (0)]
31.  Zhang H, Jiang YF, He SM, Sun J, Gu Q, Feng XW, DU B, Wang W, Shi XD, Wang CY. Etiology and prevalence of abnormal serum alanine aminotransferase levels in a general population in Northeast China. Zhonghua Yixve Zazhi. 2011;124:2661-2668.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Hosoyamada K, Uto H, Imamura Y, Hiramine Y, Toyokura E, Hidaka Y, Kuwahara T, Kusano K, Saito K, Oketani M. Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol. Diabetol Metab Syndr. 2012;4:34.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 12]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
33.  Cox LA. Low-dose nonlinear effects of smoking on coronary heart disease risk. Dose Response. 2012;10:219-232.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 7]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
34.  He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124-1134.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 865]  [Cited by in F6Publishing: 901]  [Article Influence: 47.4]  [Reference Citation Analysis (0)]
35.  Yuan H, Shyy J-YJ, Martins-Green M. Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol. 2009;51:535-547.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 80]  [Cited by in F6Publishing: 90]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
36.  Yuan H, Wong LS, Bhattacharya M, Ma C, Zafarani M, Yao M, Schneider M, Pitas RE, Martins-Green M. The effects of second-hand smoke on biological processes important in atherogenesis. BMC Cardiovasc Disord. 2007;7:1.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 51]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
37.  Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48:1-26.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 461]  [Cited by in F6Publishing: 494]  [Article Influence: 30.9]  [Reference Citation Analysis (0)]
38.  Sato R. Sterol metabolism and SREBP activation. Arch Biochem Biophys. 2010;501:177-181.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 201]  [Cited by in F6Publishing: 209]  [Article Influence: 14.9]  [Reference Citation Analysis (0)]
39.  Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest. 2008;118:829-838.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 838]  [Cited by in F6Publishing: 880]  [Article Influence: 55.0]  [Reference Citation Analysis (0)]
40.  Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006;116:1776-1783.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 691]  [Cited by in F6Publishing: 723]  [Article Influence: 40.2]  [Reference Citation Analysis (0)]
41.  Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167-1174.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 2007;33:395-402.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 126]  [Cited by in F6Publishing: 135]  [Article Influence: 7.9]  [Reference Citation Analysis (0)]
43.  Wang S, Song P, Zou MH. AMP-activated protein kinase, stress responses and cardiovascular diseases. Clin Sci (Lond). 2012;122:555-573.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 164]  [Cited by in F6Publishing: 171]  [Article Influence: 14.3]  [Reference Citation Analysis (0)]
44.  Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011;54:753-759.  [PubMed]  [DOI]  [Cited in This Article: ]
45.  Kumar R, Prakash S, Chhabra S, Singla V, Madan K, Gupta SD, Panda SK, Khanal S, Acharya SK. Association of pro-inflammatory cytokines, adipokines & amp; oxidative stress with insulin resistance & amp; non-alcoholic fatty liver disease. Indian J Med Res. 2012;136:229-236.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Wang R, Lu Q, Feng J, Yin F, Qin C, Liu B, Liu Y, Liu X. Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males. Endocrine. 2012;41:70-75.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 14]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
47.  Andreau K, Leroux M, Bouharrour A. Health and cellular impacts of air pollutants: from cytoprotection to cytotoxicity. Biochem Res Int. 2012;2012:493894.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 47]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
48.  Blanco J, Mulero M, Domingo JL, Sánchez DJ. Gestational exposure to BDE-99 produces toxicity through upregulation of CYP isoforms and ROS production in the fetal rat liver. Toxicol Sci. 2012;127:296-302.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 22]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
49.  Wu W, Peden DB, McConnell R, Fruin S, Diaz-Sanchez D. Glutathione-S-transferase M1 regulation of diesel exhaust particle-induced pro-inflammatory mediator expression in normal human bronchial epithelial cells. Part Fibre Toxicol. 2012;9:31.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 30]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
50.  Folkmann JK, Risom L, Hansen CS, Loft S, Møller P. Oxidatively damaged DNA and inflammation in the liver of dyslipidemic ApoE-/- mice exposed to diesel exhaust particles. Toxicology. 2007;237:134-144.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 54]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
51.  Tan HH, Fiel MI, Sun Q, Guo J, Gordon RE, Chen LC, Friedman SL, Odin JA, Allina J. Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol. 2009;6:266-275.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 70]  [Cited by in F6Publishing: 73]  [Article Influence: 5.2]  [Reference Citation Analysis (0)]
52.  Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103:1372-1379.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 395]  [Cited by in F6Publishing: 422]  [Article Influence: 26.4]  [Reference Citation Analysis (0)]
53.  Cave M, Falkner KC, Ray M, Joshi-Barve S, Brock G, Khan R, Bon Homme M, McClain CJ. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology. 2010;51:474-481.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 116]  [Cited by in F6Publishing: 102]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
54.  Cave M, Appana S, Patel M, Falkner KC, McClain CJ, Brock G. Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. Environ Health Perspect. 2010;118:1735-1742.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 197]  [Cited by in F6Publishing: 203]  [Article Influence: 14.5]  [Reference Citation Analysis (0)]
55.  Kelishadi R. Environmental pollution: health effects and operational implications for pollutants removal. J Environ Public Health. 2012;2012:341637.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 22]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
56.  Dijkema MB, Mallant SF, Gehring U, van den Hurk K, Alssema M, van Strien RT, Fischer PH, Nijpels G, Stehouwer CD, Hoek G. Long-term exposure to traffic-related air pollution and type 2 diabetes prevalence in a cross-sectional screening-study in the Netherlands. Environ Health. 2011;10:76.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 38]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
57.  O’Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, Horton ES, Schwartz J. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005;111:2913-2920.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 328]  [Cited by in F6Publishing: 320]  [Article Influence: 16.8]  [Reference Citation Analysis (0)]
58.  Chen JC, Schwartz J. Metabolic syndrome and inflammatory responses to long-term particulate air pollutants. Environ Health Perspect. 2008;116:612-617.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 121]  [Cited by in F6Publishing: 118]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
59.  Kim JH, Hong YC. GSTM1, GSTT1, and GSTP1 polymorphisms and associations between air pollutants and markers of insulin resistance in elderly Koreans. Environ Health Perspect. 2012;120:1378-1384.  [PubMed]  [DOI]  [Cited in This Article: ]
60.  Miao X, Wang Y, Sun J, Sun W, Tan Y, Cai L, Zheng Y, Su G, Liu Q, Wang Y. Zinc protects against diabetes-induced pathogenic changes in the aorta: roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2. Cardiovasc Diabetol. 2013;12:54.  [PubMed]  [DOI]  [Cited in This Article: ]
61.  Hosseini SM, Mousavi S, Poursafa P, Kelishadi R. Risk Score Model for Predicting Sonographic Non-alcoholic Fatty Liver Disease in Children and Adolescents. Iran J Pediatr. 2011;21:181-187.  [PubMed]  [DOI]  [Cited in This Article: ]
62.  Poursafa P, Kelishadi R, Moattar F, Rafiee L, Amin MM, Lahijanzadeh A, Javanmard SH. Genetic variation in the association of air pollutants with a biomarker of vascular injury in children and adolescents in Isfahan, Iran. J Res Med Sci. 2011;16:733-740.  [PubMed]  [DOI]  [Cited in This Article: ]
63.  Kelishadi R, Poursafa P, Keramatian K. Overweight, air and noise pollution: Universal risk factors for pediatric pre-hypertension. J Res Med Sci. 2011;16:1234-1250.  [PubMed]  [DOI]  [Cited in This Article: ]
64.  Karnik S, Kanekar A. Childhood obesity: a global public health crisis. Int J Prev Med. 2012;3:1-7.  [PubMed]  [DOI]  [Cited in This Article: ]
65.  Karakatsani A, Analitis A, Perifanou D, Ayres JG, Harrison RM, Kotronarou A, Kavouras IG, Pekkanen J, Hämeri K, Kos GP. Particulate matter air pollution and respiratory symptoms in individuals having either asthma or chronic obstructive pulmonary disease: a European multicentre panel study. Environ Health. 2012;11:75.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 71]  [Cited by in F6Publishing: 64]  [Article Influence: 5.3]  [Reference Citation Analysis (0)]
66.  Santus P, Russo A, Madonini E, Allegra L, Blasi F, Centanni S, Miadonna A, Schiraldi G, Amaducci S. How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan. Respir Res. 2012;13:95.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 77]  [Cited by in F6Publishing: 76]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
67.  Takizawa H. Impact of air pollution on allergic diseases. Korean J Intern Med. 2011;26:262-273.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 41]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
68.  Manzo ND, LaGier AJ, Slade R, Ledbetter AD, Richards JH, Dye JA. Nitric oxide and superoxide mediate diesel particle effects in cytokine-treated mice and murine lung epithelial cells--implications for susceptibility to traffic-related air pollution. Part Fibre Toxicol. 2012;9:43.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 17]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
69.  Yokota S, Ohara N, Kobayashi T. The effects of organic extract of diesel exhaust particles on ischemia/reperfusion-related arrhythmia and on pulmonary inflammation. J Toxicol Sci. 2008;33:1-10.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 13]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
70.  Thiyagarajan R, Subramanian SK, Sampath N, Madanmohan Trakroo P, Bobby Z, Paneerselvam S, Das AK. Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional study. PLoS One. 2012;7:e41889.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 21]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
71.  Jaiswal M, Urbina EM, Wadwa RP, Talton JW, D’Agostino RB, Hamman RF, Fingerlin TE, Daniels S, Marcovina SM, Dolan LM. Reduced heart rate variability among youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36:157-162.  [PubMed]  [DOI]  [Cited in This Article: ]
72.  Okwuosa TM, Klein O, Chan C, Jenny NS, Schreiner P, Green D, Liu K. 13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Atherosclerosis. 2013;226:214-219.  [PubMed]  [DOI]  [Cited in This Article: ]
73.  Goldberg MS, Burnett RT, Bailar JC, Brook J, Bonvalot Y, Tamblyn R, Singh R, Valois MF, Vincent R. The association between daily mortality and ambient air particle pollution in Montreal, Quebec. 2. Cause-specific mortality. Environ Res. 2001;86:26-36.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 98]  [Cited by in F6Publishing: 74]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
74.  Goldberg MS, Burnett RT, Yale JF, Valois MF, Brook JR. Associations between ambient air pollution and daily mortality among persons with diabetes and cardiovascular disease. Environ Res. 2006;100:255-267.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 105]  [Cited by in F6Publishing: 43]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
75.  Finelli C, Tarantino G. Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients? J Gastrointestin Liver Dis. 2012;21:293-302.  [PubMed]  [DOI]  [Cited in This Article: ]
76.  Wilson WE, Chow JC, Claiborn C, Fusheng W, Engelbrecht J, Watson JG. Monitoring of particulate matter outdoors. Chemosphere. 2002;49:1009-1043.  [PubMed]  [DOI]  [Cited in This Article: ]
77.  Weinberg JM, Buchholz B.  Introduction to TNF. TNF-alpha Inhibitors. New York: Birkhauser Verlag 2006; .  [PubMed]  [DOI]  [Cited in This Article: ]
78.  Wang G, Jiang R, Zhao Z, Song W. Effects of ozone and fine particulate matter (PM(2.5)) on rat system inflammation and cardiac function. Toxicol Lett. 2012;217:23-33.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 75]  [Cited by in F6Publishing: 79]  [Article Influence: 6.6]  [Reference Citation Analysis (0)]